These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8126146)

  • 21. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
    Bloch M; Rubinow DR; Berlin K; Kevala KR; Kim HY; Schmidt PJ
    Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.
    Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of androgen on sexual behavior in hypogonadal men.
    Davidson JM; Camargo CA; Smith ER
    J Clin Endocrinol Metab; 1979 Jun; 48(6):955-8. PubMed ID: 447801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
    Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man.
    Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS
    J Androl; 1994; 15(1):22-8. PubMed ID: 8188535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
    Matsumoto AM; Karpas AE; Bremner WJ
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of pharmacologically induced hypogonadism on mood in healthy men.
    Schmidt PJ; Berlin KL; Danaceau MA; Neeren A; Haq NA; Roca CA; Rubinow DR
    Arch Gen Psychiatry; 2004 Oct; 61(10):997-1004. PubMed ID: 15466673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men.
    Matthiesson KL; Stanton PG; O'Donnell L; Meachem SJ; Amory JK; Berger R; Bremner WJ; McLachlan RI
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5647-55. PubMed ID: 16030154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid protection of rat spermatogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide).
    Kangasniemi M; Wilson G; Parchuri N; Huhtaniemi I; Meistrich ML
    Endocrinology; 1995 Jul; 136(7):2881-8. PubMed ID: 7789313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sexual effects of testosterone replacement in depressed men: randomized, placebo-controlled clinical trial.
    Seidman SN; Roose SP
    J Sex Marital Ther; 2006; 32(3):267-73. PubMed ID: 16809253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.
    Lee H; Finkelstein JS; Miller M; Comeaux SJ; Cohen RI; Leder BZ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1069-75. PubMed ID: 16352679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologically induced hypogonadism and sexual function in healthy young women and men.
    Schmidt PJ; Steinberg EM; Negro PP; Haq N; Gibson C; Rubinow DR
    Neuropsychopharmacology; 2009 Feb; 34(3):565-76. PubMed ID: 18354393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections.
    Rochira V; Balestrieri A; Madeo B; Granata AR; Carani C
    J Androl; 2006; 27(2):165-75. PubMed ID: 16278367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
    Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men.
    Jockenhövel F; Minnemann T; Schubert M; Freude S; Hübler D; Schumann C; Christoph A; Ernst M
    Eur J Endocrinol; 2009 May; 160(5):815-9. PubMed ID: 19225035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.
    Dobs AS; Bachorik PS; Arver S; Meikle AW; Sanders SW; Caramelli KE; Mazer NA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1026-33. PubMed ID: 11238481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.